TABLE 2. Analysis of serum neutralization mechanism.
Neutralization activity of various plasma against JR-FL-based VLPs was analyzed in various formats. As in Table 1, neutralization formats are organized in columns. IC50 data are given as reciprocal plasma dilutions. Neutralization has been color-coded in a similar manner to Table 1. N.D.=not done. JR-FL gp120 ELISA titers for each serum against gp120 are shown. IC50 data not shown in the table for plasmas N308, A62, L909, and TN15 were 4,000, 300, 170 and 67, respectively against gp160WT-VLPs in the standard format and 15,000, 3,000, 150 and 99 against gp160ΔCT WT-VLPs in the standard format.
| column | 1 | 2 | 3 | ||
|---|---|---|---|---|---|
| format | standard | post-CD4 | post-CD4/CCR5 | ||
| WT/SOS | WT | SOS | |||
| IC50 titer: | human plasma | gp120 titer | |||
| <50 | N308 | 250,000 | 9,000 | 240,000 | <40 |
| 50-300 | A62 | 100,000 | 2,000 | 89,600 | <40 |
| 300-1000 | #11H | 500,000 | 1,000 | 90,000 | <40 |
| 1000-3000 | L92 | 1,000,000 | 400 | 500,000 | <40 |
| >3000 | L909 | 1,500,000 | 320 | 309,000 | <40 |
| R2 | 600,000 | 150 | 500,000 | <40 | |
| 739 | 80,000 | 100 | 200,000 | <40 | |
| TN15 | 603,000 | 64 | 143,000 | 40 | |
| J864 | 248,000 | 50 | 84,000 | <40 | |
| N160 | 500,000 | <40 | 160,000 | <40 | |
| K370 | 381,000 | <40 | 100,000 | <40 | |
| TN11 | 119,000 | <40 | 19,000 | <40 | |
| L503 | 612,000 | <40 | 162,000 | <40 | |
| HIV- | <300 | <40 | 250 | <40 | |
| spiked human plasma | |||||
| J864 | 248,000 | 50 | 84,000 | <40 | |
| J864+b12 | N.D. | 950 | 90,000 | <10 | |
| J864+2G12 | N.D. | 120 | 80,000 | <10 | |
| J864+2F5 | N.D. | 110 | 82,000 | 71 | |